Showing results (81-90 of 116) with videos related to
Sort By:
Pageof 12
Nature Genetics|October 28, 2025
Cellular states associated with metastatic organotropism and survival in patients with pancreatic ductal adenocarcinomaMorteza Chalabi Hajkarim, Michael May, Amit Dipak Amin, et al.Journal for Immunotherapy of Cancer|October 18, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0Anna C Pavlick, Charlotte E Ariyan, Elizabeth I Buchbinder, et al.Nature|August 23, 2023
Non-cell-autonomous cancer progression from chromosomal instabilityJun Li, Melissa J Hubisz, Ethan M Earlie, et al.Science (New York, N.Y.)|August 29, 2024
Micronuclear collapse from oxidative damageMelody Di Bona, Yanyang Chen, Albert S Agustinus, et al.Biorxiv : the Preprint Server for Biology|July 14, 2025
Chromosomal instability shapes the tumor microenvironment of esophageal adenocarcinoma via a cGAS-chemokine-myeloid axisBruno Beernaert, Rose L Jady-Clark, Parin Shah, et al.Pigment Cell & Melanoma Research|October 7, 2023
Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA)Alexander Z Wei, Lanyi N Chen, Marlana Orloff, et al.Cell|July 1, 2017
IFNγ-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor MicroenvironmentChristopher J Nirschl, Mayte Suárez-Fariñas, Benjamin Izar, et al.JCO Precision Oncology|June 12, 2026
Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Clinical Models: MEKiAUTOBrian W Labadie, Aleksandar Obradovic, Alexander G Raufi, et al.Cell|February 1, 2024
SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasionGiuseppe Leuzzi, Alessandro Vasciaveo, Angelo Taglialatela, et al.Nature|September 10, 2025
Neuronal activity-dependent mechanisms of small cell lung cancer pathogenesisSolomiia Savchuk, Kaylee M Gentry, Wengang Wang, et al.Pageof 12